AAPG
Ascentage Pharma Group International Co., Ltd.
NASDAQ · Healthcare · Biotechnology · CN
$15.36
−0.07%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- -$0.30
- Revenue estimate
- $49.8M
Latest reported
- Last report date
- Aug 20, 2026
- EPS actual
- -$1.28
- EPS estimate
- $0.02
- Revenue actual
- $44.0M
- Revenue estimate
- $24.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -4651.1%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $41
- PT range
- $33 – $48
- Analysts
- 5
5 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 20, 2026 | $0.02 | -$1.28 | Miss -7840.44% | $44.0M |
| Mar 26, 2026 | -$0.83 | -$0.65 | Beat 21.69% | $49.5M |
| Aug 7, 2025 | — | -$0.96 | — | $32.6M |
| Mar 27, 2025 | $0.02 | -$1.00 | Miss -6134.62% | $21.5M |
| Aug 22, 2024 | — | $0.31 | — | $115.4M |
| Jun 30, 2024 | — | $0.30 | — | $113.4M |
| Dec 31, 2023 | — | -$1.02 | — | $11.2M |
| Aug 21, 2023 | — | -$0.81 | — | $19.6M |
| Jun 30, 2023 | — | -$3.15 | — | $19.7M |
| Dec 31, 2022 | — | -$3.91 | — | $15.3M |
| Aug 26, 2022 | — | -$0.89 | — | $13.8M |
| Jun 30, 2022 | — | -$4.00 | — | $15.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027